AzTrials
AzTrials

Intubation; DifficultC-MACNCT01104090

Initial Experience With Storz C-MAC Video Intubation System

A study testing C-MAC direct laryngoscopy and C-MAC Indirect laryngoscopy in people with Intubation; Difficult, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the safety and efficacy of the C-MAC (Karl Storz Endoscopy, Inc., Tuttlingen, Germany) video intubation system guided intubation techniques. We hypothesize that the C-MAC video laryngoscope is safe and efficacious in terms of successful endotracheal intubation. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Intubation; Difficult
What is being tested?
C-MAC direct laryngoscopy and C-MAC Indirect laryngoscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
Feb 2010to Feb 2012
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 - 80 years of age
  • ASA I - III
  • Mallampati I-III
  • Mouthopening > 4cm

Who cannot join

  • Age < 18 years and > 80 years of age
  • ASA IV - V
  • Mallampati IV - V
  • Mouthopening < 4cm

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Memorial Hermann Hospital

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this study is to determine the safety and efficacy of the C-MAC (Karl Storz Endoscopy, Inc., Tuttlingen, Germany) video intubation system guided intubation techniques.

We hypothesize that the C-MAC video laryngoscope is safe and efficacious in terms of successful endotracheal intubation. The C-MAC may be a safe and suitable alternative device for routine and difficult laryngoscopy and tracheal intubation. This is the first study to investigate the performance of C-MAC in clinical practice.

Read the detailed description

Since the introduction of the laryngoscope into clinical anesthesia practice, innovators have attempted to improve upon and perfect the design of the laryngoscope blade. The goal of these innovations has been to improve visualization of laryngeal structures and increase the likelihood of successful tracheal intubation.

It is estimated that endotracheal intubation is performed on some 8 million patients per year in the United States. Of these endotracheal intubations, approximately 80% are performed by direct laryngoscopy with transoral placement of the endotracheal tube (ET) into the trachea. The incidence of unsuspected difficult intubation is estimated to be higher at approximately 3%. One factor that contributes to difficult intubation is poor visualization of the airway.

Video laryngoscopes are a relatively new edition to the armamentarium of airway devices available to the airway manager. Although these instruments are more expensive than traditional direct laryngoscopes, they offer several advantages that may justify their expense. While many clinicians may espouse the routine use of video laryngoscopy, most providers advocate its use for anticipated difficult situations, or as "plan B" after failed intubation by direct laryngoscopy (DL).

The video laryngoscopes have been shown to provide superior views to traditional laryngoscopy in normal and difficult intubation situations.3-6 Video intubation techniques, by allowing tracheal intubation monitoring, improve the safety of the procedure and increase intubation success. In contrast, using conventional laryngoscopy, anesthesiologists have only a "keyhole" view of the airway structures; a view that may be further obscured during attempts to pass the ET tube.

The C-MAC video laryngoscope is the latest edition to the pool of video laryngoscopes. C-MAC is a further development of the V-MAC (Karl Storz Endoscopy, Inc., Tuttlingen, Germany) video laryngoscope. The C-MAC became commercially available in US in March 2009 and at this time; there are no studies available regarding its use in clinical practice.

The device consists of a laryngoscope handle and Macintosh blade that have been modified to provide a video image of airway structures on a screen, which can be conveniently located directly in front of the anesthesiologist. A micro video module based on CMOS image sensor technology is contained in the modified handle and an image/light bundle is introduced into the standard blade. Because of its design, this is the video laryngoscope system which can be used to perform either a direct or indirect laryngoscopy.

  1. General Study Design-

The study will include a total of 50 patients. All patients will be intubated using conventional endotracheal tube preferably without any alternative aid.

In the operating room, standard monitoring devices will be applied including a pulse oximeter, 3 lead (at least), ECG and blood pressure cuff; the latter could be invasive or non-invasive depending on the nature of the surgery. Baseline measures of BP, pulse, oxygen saturation, and CO2, will be made. The time will be noted before any sedation or anesthesia is administered. Vital signs will be recorded every minute from the time that induction of anesthesia is begun until five minutes after the patient has been intubated, and then at five-minute intervals thereafter for fifteen minutes.

General anesthesia will be induced by bolus administration of propofol (2-3 mg/kg) and fentanyl (1-2 mcg/kg), and maintained with an inhalational agent. Rocuronium (0.6 mg/kg) will be administered, after face mask ventilabilty being checked, to provide muscle relaxation and a mixture of sevoflurane or isoflurane and nitrous oxide (per anesthesiologist choice) will be utilized for maintenance of anesthesia once the ability to mask ventilate is confirmed. The lungs will be mechanically ventilated with a semi-closed circle system to maintain an end-tidal CO2 near 35 mmHg. Patients' lungs will be ventilated via an anesthesia mask for five minutes with 100% oxygen until the patient is completely relaxed.

All investigators, residents and attendings, will be trained based on manufacturer recommendations, and each resident will perform at least 3 intubations with C-MAC video laryngoscope prior to enlisting any patients for the study. Intubations will be performed by 2nd and 3rd year (CA-2 and CA-3) residents. The resident will perform direct laryngoscopy utilizing C-MAC followed by the video laryngoscopy or vice versa. In an effort to prevent bias, a computer-generated list will be prepared to help randomize the order of execution between direct laryngoscopy and indirect video laryngoscopy; intubations will be performed during the second method used. The resident will first take a direct look at the larynx without manipulating the scope. Then, the resident will take a video-assisted look (or vice versa). Subsequently, the operator will compare the direct view with the video-assisted view, then intubate. He/she will record an observation of the laryngeal aperture for both based on the Cormack-Lehane Scale and a percentage of glottic opening score (POGO Score). External neck pressure may be applied by an assistant in an attempt to improve exposure of the larynx. The anesthesiologist's assessment of the optimal view obtained by these maneuvers will be recorded.

To clarify, residents will have only one attempt opportunity each for direct laryngoscopy and in-direct video assisted laryngoscopy. If, after the first unsuccessful attempt, the attending anesthesiologist will take one more attempt respectively for the direct and in-direct views. Between laryngoscopy attempts, the intubator will achieve easy patient ventilation before the next attempt is made. The number of attempts (maximum 4 total) measured as either the reinsertion of the blade or endotracheal tube) and the intubation time (time the laryngoscope blade enters the mouth until 1st capnograph breath) will also be recorded. If unsuccessful, the direct laryngoscopy/ flexible fibreoptic laryngoscopy will be performed to intubate the trachea. If more than 4 attempts (two maximum for each type of laryngoscopy) were needed or if the anesthesiologist discontinued use of the video laryngoscope, the case will be deemed a failure. The subjective level of difficulty (from 0 = Extremely Easy to 5 = Extremely Difficult) in the performance of intubation will also be recorded.

There is a plan to do the second phase of the study. This will include a total of 50 patients with anticipated difficult airway (limited mouth opening, restricted neck movement, Mallampati 4, thyromental distance < 6 cm, BMI ≥ 40 kg/m2). All patients will be adult surgical candidates aged 18-80 years, ASA I- III, presenting for elective surgery who require general endotracheal anesthesia. We hypothesize that the C-MAC may be a safer and suitable alternative device for both routine and difficult laryngoscopy and tracheal intubation.

  1. Measurements We will record morphometric characteristics of all patients. The quality of the airway will be evaluated using the Mallampati, thyromental distance, interincisor gap distance, neck mobility and circumference, and sternomental distance. All intubators will note their laryngoscopy experience level (Cormack-Lehane Scale modified by Yentis, POGO score). Additionally, the anesthesiologist will provide a personal, subjective opinion of a possible difficult laryngoscopy and intubation based on scale from 1 to 5. Any evidence of fogging on the lens will be noted.

Intubation: We will measure the time and number of attempts required for successful endotracheal intubation, easiness of double view (direct vs video), laryngoscopy view change, and any alternative aid (bougie, stylet, etc) required. An attempt is defined as placement of an ETT through the glottic opening and into the trachea. Removal/reinsertion of the laryngoscope or the switching of the laryngoscopist will constitute as a new attempt. Once an optimal positional has been confirmed, position of the ETT will not be further altered. A four question survey will be presented to the resident (is it easy to be used, is it intuitive, do you think it is valuable as a teaching tool, what do you think is the greatest/ worst value of this device).

Degree of irritation: Following intubation in either group, the appearance of oropharynx, pharynx, epiglottis, and arytenoids will be checked. The presence of abrasions, bleeding, redness, perforation or other signs of tissue or dental injury will be recorded.

SUBJECTS:

The subjects will be adult surgical candidates age 18-80, ASA I- III, presenting for elective surgery who require general anesthesia. Patients will be chosen if it is determined that endotracheal intubation is required. Patients will be excluded if they are considered so difficult (i.e. Mallampatti IV, < 2 FB or 4 cm mouth opening), that an awake fiberoptic intubation should be performed. ASA IV and V patients will also be excluded from the study in addition to those who need rapid sequence (i.e. patients with acid reflux) and have known cardiovascular disease

RECRUITMENT METHODS/ INFORMED CONSENT:

Physician investigators will interview all potential subjects to determine if subjects are suitable for the study. Written consent will be obtained by an anesthesiology resident or research assistant.

PROCEDURES TO MAINTAIN CONFIDENTIALITY:

All information recorded on the anesthetic records will be kept strictly confidential and all data will be kept in a data logbook locked in the office of the principal investigator. We will record patients only by study code number.

DATA ANALYSIS:

Data will be analyzed using t- tests, ANOVA, or Fisher Exact test, as appropriate. Results will be presented as means ± SD. P < 0.05 will be considered as statistically significant.

Being tested
C-MAC direct laryngoscopy, C-MAC Indirect laryngoscopy
Keywords
C-MAC, direct laryngoscopy, indirect laryngoscopy, to determine the safety and efficacy of the C-MAC

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • C-MAC direct laryngoscopyDevice

    Patients will be intubated using C-MAC with direct laryngoscopy.

  • C-MAC Indirect laryngoscopyDevice

    Patients will be intubated using C-MAC with indirect laryngoscopy.

Study groups in NCT01104090
Study groupRoleWhat they receive
C-MAC direct laryngoscopy, then C-MAC indirect laryngoscopyExperimentalPatients assigned to this arm will be intubated using C-MAC with direct laryngoscopy first and then using C-MAC with indirect laryngoscopy.
Receives: Device: C-MAC direct laryngoscopy; Device: C-MAC Indirect laryngoscopy
C-MAC indirect laryngoscopy, then C-MAC direct laryngoscopyExperimentalPatients assigned to this arm will be intubated using C-MAC with indirect laryngoscopy first and then using C_MAC with direct laryngoscopy.
Receives: Device: C-MAC direct laryngoscopy; Device: C-MAC Indirect laryngoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time for Intubation

    Time taken for successful placement of endotracheal tube (that is, intubation).

    Measured: at the time of intubation (about 10 seconds)

Secondary outcomes (6)
  1. Laryngoscopy Time

    Laryngoscopy time is defined as the time between advancing the laryngoscopy and obtaining the optimal view of the airway.

    Measured: at the time of laryngoscopy (about 10 seconds)

  2. Airway View at the Time of Laryngoscopy as Categorized by the Modified Cormack-Lehane Classification (Before External Manipulation)

    Modified Cormack-Lehane classification:

    1. Full view of glottis
    2. a Partial view of glottis

    2b Only posterior extremity of glottis seen or only arytenoid cartilages 3 Only epiglottis seen, none of glottis seen 4 Neither glottis nor epiglottis seen

    Measured: at the time of laryngoscopy (about 10 seconds)

  3. Airway View at the Time of Laryngoscopy as Categorized by the Modified Cormack-Lehane Classification (After External Manipulation)

    Modified Cormack-Lehane classification:

    1. Full view of glottis
    2. a Partial view of glottis

    2b Only posterior extremity of glottis seen or only arytenoid cartilages 3 Only epiglottis seen, none of glottis seen 4 Neither glottis nor epiglottis seen

    Measured: at the time of laryngoscopy (about 10 seconds)

  4. Number of Participants With Successful Intubation

    Measured: at the time of intubation (about 10 seconds)

  5. Ease of Intubation as Assessed by a Rating Scale

    Ease of intubation as assessed by a rating scale, which ranged from 1 (very easy) to 5 (very difficult).

    Measured: at the time of intubation (about 10 seconds)

  6. Ease of Laryngoscopy as Assessed by a Rating Scale

    Ease of laryngoscopy as assessed by a rating scale, which ranged from 1 (very easy) to 5 (very difficult).

    Measured: at the time of laryngoscopy (about 10 seconds)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2010 (estimated)
  2. Study startFeb 2010
  3. Primary completionSep 2010
  4. Study completionFeb 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01104090
Sponsor's protocol ID
HSC-MS-09-0161
Acronym
C-MAC
Status last verified
Oct 2021
First submitted
13 Apr 2010
Last updated
1 Nov 2021
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing C-MAC direct laryngoscopy and C-MAC Indirect laryngoscopy in people with Intubation; Difficult, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 1 Nov 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time for Intubation (time frame: at the time of intubation (about 10 seconds)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2021; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in